Operating
United Therapeutics·Cash Flow Statement·20 metrics
Breakdown
| Metric | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $232.2M | $377.2M | $341.2M | $461.2M | $191.7M | $562.1M | $346.2M | $463.3M |
| Net income | $278.1M | $309.1M | $301.3M | $322.2M | $309.5M | $338.7M | $364.3M | $274.9M |
| Net gains (losses) on investments | — | — | — | -$5.3M | — | — | — | -$61.6M |
| Change in inventories | $14.7M | $11.3M | $11.6M | $11.2M | $7.4M | $17.5M | $16.5M | $40.1M |
| Change in accounts receivable | — | $51.1M | — | $42.7M | $57.3M | — | $52.5M | -$38.2M |
| Stock-based compensation | $49.7M | $41.7M | $27.0M | $31.8M | $37.8M | $39.1M | $39.0M | $33.9M |
| Other non-cash income (expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other non-cash income (expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-Cash Income (Expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-cash Income (Expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-cash Income (Expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other non-cash income (expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Noncash Income (Expense) | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-cash Income and Expense | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-Cash Adjustments | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other Non-Cash Income and Expense | $5.5M | $5.7M | $2.6M | -$4.1M | -$9.9M | $100.0K | $33.6M | -$32.0M |
| Other working capital changes | $136.4M | -$42.4M | -$27.0M | -$134.5M | $184.4M | -$67.2M | $98.2M | -$27.0M |
| Deferred income taxes | -$16.0M | -$16.0M | -$16.0M | $0.0 | — | — | — | $25.9M |
| Depreciation and amortization | $18.7M | $19.1M | $19.7M | $19.8M | $21.1M | $21.9M | $22.8M | $22.6M |
| Change in accounts payable | $25.8M | $33.0M | — | -$2.6M | $46.1M | $31.2M | $23.2M | -$12.7M |